Standout Papers

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smoke... 2012 2026 2016 2021 599
  1. First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung (2012)
    Ji‐Youn Han, Keunchil Park et al. Journal of Clinical Oncology

Immediate Impact

2 from Science/Nature 110 standout
Sub-graph 1 of 18

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Molecular and functional imaging in cancer-targeted therapy: current applications and future directions
2023 Standout
8 intermediate papers

Works of Cheolwon Suh being referenced

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
2012 Standout
[18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
2008
and 1 more

Author Peers

Author Last Decade Papers Cites
Cheolwon Suh 836 653 42 190 9 949
Gonçalo Forjaz 614 568 56 234 11 1.1k
Pierpaolo Camplese 799 616 35 266 15 965
Bianco Ar 428 607 47 325 7 831
Kristina Lamberg 412 402 30 191 20 762
Damiano 433 604 44 327 5 837
Peter F. Lenehan 413 459 77 265 17 817
Anna Bettini 564 570 95 197 25 857
Pil Gyu Hwang 982 851 47 337 11 1.1k
Joan Lucca 736 671 47 193 25 998
Ursula Vogl 410 392 69 336 20 864

All Works

Loading papers...

Rankless by CCL
2026